| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.33 | 2e-12 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.35 | 6e-10 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.31 | 6e-08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 1e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |